{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:58:58Z","timestamp":1791233938283,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01926-2","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T02:29:54Z","timestamp":1763432994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CDKN1A and cellular senescence are associated with immune resistance in advanced lung adenocarcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Wang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feidie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yezhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1926_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1926_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13073-021-01010-w","volume":"14","author":"TT Nguyen","year":"2022","unstructured":"Nguyen TT, et al. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022;14:5.","journal-title":"Genome Med"},{"key":"1926_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-16-2490","volume":"77","author":"FS Varn","year":"2017","unstructured":"Varn FS, Wang Y, Mullins DW, Fiering S, Cheng C. Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment. Cancer Res. 2017;77:1271\u201382.","journal-title":"Cancer Res"},{"key":"1926_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627\u201339.","journal-title":"N Engl J Med"},{"key":"1926_CR5","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387:1540\u201350.","journal-title":"Lancet"},{"key":"1926_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3294","volume":"23","author":"A Dong","year":"2021","unstructured":"Dong A, Zhao Y, Li Z, Hu H. PD-L1 versus tumor mutation burden: which is the better immunotherapy biomarker in advanced non-small cell lung cancer? J Gene Med. 2021;23:e3294.","journal-title":"J Gene Med"},{"key":"1926_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS el-Deiry","year":"1993","unstructured":"el-Deiry WS, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817\u201325.","journal-title":"Cell"},{"key":"1926_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805\u201316.","journal-title":"Cell"},{"key":"1926_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","volume":"23","author":"AG Georgakilas","year":"2017","unstructured":"Georgakilas AG, Martin OA, Bonner WM. P21: a two-faced genome guardian. Trends Mol Med. 2017;23:310\u20139.","journal-title":"Trends Mol Med"},{"key":"1926_CR10","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1158\/0008-5472.CAN-16-2055","volume":"76","author":"WS El-Deiry","year":"2016","unstructured":"El-Deiry WS. p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy. Cancer Res. 2016;76:5189\u201391.","journal-title":"Cancer Res"},{"key":"1926_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1101\/gad.1205304","volume":"18","author":"C Denicourt","year":"2004","unstructured":"Denicourt C, Dowdy SF. Cip\/kip proteins: more than just CDKs inhibitors. Genes Dev. 2004;18:851\u20135.","journal-title":"Genes Dev"},{"key":"1926_CR12","first-page":"639","volume":"1","author":"AL Gartel","year":"2002","unstructured":"Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 2002;1:639\u201349.","journal-title":"Mol Cancer Ther"},{"key":"1926_CR13","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1074\/jbc.M306968200","volume":"279","author":"S Lee","year":"2004","unstructured":"Lee S, Helfman DM. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK\/LIMK\/cofilin pathway. J Biol Chem. 2004;279:1885\u201391.","journal-title":"J Biol Chem"},{"key":"1926_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.devcel.2010.10.013","volume":"19","author":"NG Starostina","year":"2010","unstructured":"Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET. CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells. Dev Cell. 2010;19:753\u201364.","journal-title":"Dev Cell"},{"key":"1926_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100373","author":"A Maiuthed","year":"2018","unstructured":"Maiuthed A, et al. Cytoplasmic p21 mediates 5-fluorouracil resistance by inhibiting pro-apoptotic Chk2. Cancers (Basel). 2018. https:\/\/doi.org\/10.3390\/cancers10100373.","journal-title":"Cancers (Basel)"},{"key":"1926_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/1471-2407-11-399","volume":"11","author":"X Xia","year":"2011","unstructured":"Xia X, et al. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer. BMC Cancer. 2011;11:399.","journal-title":"BMC Cancer"},{"key":"1926_CR17","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1172\/JCI41939","volume":"120","author":"R Koster","year":"2010","unstructured":"Koster R, et al. Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest. 2010;120:3594\u2013605.","journal-title":"J Clin Invest"},{"key":"1926_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101652","volume":"67","author":"DA Englund","year":"2023","unstructured":"Englund DA, et al. p21 induces a senescence program and skeletal muscle dysfunction. Mol Metab. 2023;67:101652.","journal-title":"Mol Metab"},{"key":"1926_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi J, di d\u2019Adda Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8:729\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1926_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313173","author":"L Roger","year":"2021","unstructured":"Roger L, Tomas F, Gire V. Mechanisms and regulation of cellular senescence. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222313173.","journal-title":"Int J Mol Sci"},{"key":"1926_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.it.2015.02.009","volume":"36","author":"A Lasry","year":"2015","unstructured":"Lasry A, Ben-Neriah Y. Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol. 2015;36:217\u201328.","journal-title":"Trends Immunol"},{"key":"1926_CR22","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"J-P Copp\u00e9","year":"2008","unstructured":"Copp\u00e9 J-P, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853\u201368.","journal-title":"PLoS Biol"},{"key":"1926_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ncb1909","volume":"11","author":"F Rodier","year":"2009","unstructured":"Rodier F, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11:973\u20139.","journal-title":"Nat Cell Biol"},{"key":"1926_CR24","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007;445:656\u201360.","journal-title":"Nature"},{"key":"1926_CR25","doi-asserted-by":"publisher","first-page":"11762","DOI":"10.1038\/ncomms11762","volume":"7","author":"MK Ruhland","year":"2016","unstructured":"Ruhland MK, et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. 2016;7:11762.","journal-title":"Nat Commun"},{"key":"1926_CR26","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","volume":"41","author":"LI Prieto","year":"2023","unstructured":"Prieto LI, et al. Senescent alveolar macrophages promote early-stage lung tumorigenesis. Cancer Cell. 2023;41:1261-1275.e6.","journal-title":"Cancer Cell"},{"key":"1926_CR27","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22:340\u201355.","journal-title":"Nat Rev Cancer"},{"key":"1926_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer: role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"1926_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41588-023-01355-5","volume":"55","author":"A Ravi","year":"2023","unstructured":"Ravi A, et al. Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. Nat Genet. 2023;55:807\u201319.","journal-title":"Nat Genet"},{"key":"1926_CR30","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. 2021;12:2540.","journal-title":"Nat Commun"},{"key":"1926_CR31","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","volume":"40","author":"S Salcher","year":"2022","unstructured":"Salcher S, et al. High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell. 2022;40:1503-1520.e8.","journal-title":"Cancer Cell"},{"key":"1926_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1926_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"1926_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. Xcell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"1926_CR35","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138.","journal-title":"Nat Med"},{"key":"1926_CR36","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul D, et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun. 2022;13:4827.","journal-title":"Nat Commun"},{"key":"1926_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19:15.","journal-title":"Genome Biol"},{"key":"1926_CR38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","volume":"36","author":"K Pola\u0144ski","year":"2020","unstructured":"Pola\u0144ski K, et al. BBknn: fast batch alignment of single cell transcriptomes. Bioinformatics. 2020;36:964\u20135.","journal-title":"Bioinformatics"},{"key":"1926_CR39","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"1926_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"P Badia-I-Mompel","year":"2022","unstructured":"Badia-I-Mompel P, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinformatics Adv. 2022;2:vbac016.","journal-title":"Bioinformatics Adv"},{"issue":"Suppl","key":"1926_CR41","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/S0049-3848(20)30406-0","volume":"191","author":"W Ruf","year":"2020","unstructured":"Ruf W, Graf C. Coagulation signaling and cancer immunotherapy. Thromb Res. 2020;191(Suppl):S106\u201311.","journal-title":"Thromb Res"},{"key":"1926_CR42","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","volume":"27","author":"M Taki","year":"2021","unstructured":"Taki M, et al. Tumor immune microenvironment during epithelial-mesenchymal transition. Clin Cancer Res. 2021;27:4669\u201379.","journal-title":"Clin Cancer Res"},{"key":"1926_CR43","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2022.02.024","volume":"162","author":"CJ Garcia Garcia","year":"2022","unstructured":"Garcia Garcia CJ, et al. Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment. Gastroenterology. 2022;162:2018\u201331.","journal-title":"Gastroenterology"},{"key":"1926_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.molcel.2022.12.023","volume":"83","author":"M Ghosh","year":"2023","unstructured":"Ghosh M, Saha S, Li J, Montrose DC, Martinez LA. p53 engages the cGAS\/STING cytosolic DNA sensing pathway for tumor suppression. Mol Cell. 2023;83:266-280.e6.","journal-title":"Mol Cell"},{"key":"1926_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0167-5699(00)01750-3","volume":"21","author":"GF Gao","year":"2000","unstructured":"Gao GF, Jakobsen BK. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Immunol Today. 2000;21:630\u20136.","journal-title":"Immunol Today"},{"key":"1926_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74\u201380.","journal-title":"Science"},{"key":"1926_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellsig.2018.03.010","volume":"47","author":"M Zaremba-Czogalla","year":"2018","unstructured":"Zaremba-Czogalla M, et al. A novel regulatory function of CDKN1A\/p21 in TNF\u03b1-induced matrix metalloproteinase 9-dependent migration and invasion of triple-negative breast cancer cells. Cell Signal. 2018;47:27\u201336.","journal-title":"Cell Signal"},{"key":"1926_CR48","doi-asserted-by":"publisher","first-page":"14877","DOI":"10.1074\/jbc.M200373200","volume":"277","author":"SR Schwarze","year":"2002","unstructured":"Schwarze SR, et al. Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem. 2002;277:14877\u201383.","journal-title":"J Biol Chem"},{"key":"1926_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","volume":"132","author":"N Wajapeyee","year":"2008","unstructured":"Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132:363\u201374.","journal-title":"Cell"},{"key":"1926_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol. 2016;39:1\u20136.","journal-title":"Curr Opin Immunol"},{"key":"1926_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41:450\u201365.","journal-title":"Cancer Cell"},{"key":"1926_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/CJI.0b013e3181b91c9c","volume":"33","author":"JK Mulligan","year":"2010","unstructured":"Mulligan JK, Rosenzweig SA, Young MRI. Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2. J Immunother. 2010;33:126\u201335.","journal-title":"J Immunother"},{"key":"1926_CR53","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun. 2023;14:5110.","journal-title":"Nat Commun"},{"key":"1926_CR54","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen Z, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11:5077.","journal-title":"Nat Commun"},{"key":"1926_CR55","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","volume":"52","author":"\u00c1 Teijeira","year":"2020","unstructured":"Teijeira \u00c1, et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity. 2020;52:856-871.e8.","journal-title":"Immunity"},{"key":"1926_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2025","unstructured":"Yan Y, et al. Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Nat Genet. 2025;57:126\u201339.","journal-title":"Nat Genet"},{"key":"1926_CR57","doi-asserted-by":"publisher","first-page":"13380","DOI":"10.18632\/aging.203110","volume":"13","author":"JA L\u00f3pez-Dom\u00ednguez","year":"2021","unstructured":"L\u00f3pez-Dom\u00ednguez JA, et al. Cdkn1a transcript variant 2 is a marker of aging and cellular senescence. Aging. 2021;13:13380\u201392.","journal-title":"Aging"},{"key":"1926_CR58","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","volume":"17","author":"A Winer","year":"2018","unstructured":"Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol Cancer Ther. 2018;17:1147\u201355.","journal-title":"Mol Cancer Ther"},{"key":"1926_CR59","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387\u201392.","journal-title":"Science"},{"key":"1926_CR60","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10585-020-10041-3","volume":"37","author":"A Spanopoulou","year":"2020","unstructured":"Spanopoulou A, Gkretsi V. Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients. Clin Exp Metastasis. 2020;37:451\u201364.","journal-title":"Clin Exp Metastasis"},{"key":"1926_CR61","first-page":"1981","volume":"42","author":"J Wang","year":"2019","unstructured":"Wang J, Hu Z-G, Li D, Xu J-X, Zeng Z-G. Gene expression and prognosis of insulin-like growth factor-binding protein family members in non-small cell lung cancer. Oncol Rep. 2019;42:1981\u201395.","journal-title":"Oncol Rep"},{"key":"1926_CR62","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3892\/ijo.2017.3927","volume":"50","author":"T Huang","year":"2017","unstructured":"Huang T, et al. FGF7\/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. Int J Oncol. 2017;50:1501\u201312.","journal-title":"Int J Oncol"},{"key":"1926_CR63","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.ccell.2023.05.004","volume":"41","author":"S Haston","year":"2023","unstructured":"Haston S, et al. Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer. Cancer Cell. 2023;41:1242-1260.e6.","journal-title":"Cancer Cell"},{"key":"1926_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06119-x","author":"J Fang","year":"2023","unstructured":"Fang J, et al. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis. 2023. https:\/\/doi.org\/10.1038\/s41419-023-06119-x.","journal-title":"Cell Death Dis"},{"key":"1926_CR65","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.12.017","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, et al. NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion. Acta Pharm Sin B. 2022;12:2859\u201368.","journal-title":"Acta Pharm Sin B"},{"key":"1926_CR66","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7150\/ijbs.37275","volume":"16","author":"H Li","year":"2020","unstructured":"Li H, et al. Integrin \u03b11 promotes tumorigenicity and progressive capacity of colorectal cancer. Int J Biol Sci. 2020;16:815\u201326.","journal-title":"Int J Biol Sci"},{"key":"1926_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"1926_CR68","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/gcc.23121","volume":"62","author":"D Tolomeo","year":"2023","unstructured":"Tolomeo D, et al. CircPVT1 and PVT1\/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer. Genes Chromosomes Cancer. 2023;62:377\u201391.","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01926-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:09:28Z","timestamp":1763446168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01926-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01926-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F Duan, P Cui, Y Shi, L Zhang, X Mi, Y Xu, G Wang, and S Cai are employees of Burning Rock Biotech. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14"}}